Neil Berkley

Neil Berkley's Title

Neil Berkley is currently serving as the Chief Business Officer, a role in which he oversees strategic business initiatives, corporate development, and partnerships. His extensive experience in the biotech industry positions him as a critical leader in driving business growth and innovation.

Neil Berkley's Education and Expertise

Neil Berkley holds a B.S. in Molecular Biology from UC San Diego, an M.S. in Cellular and Molecular Biology, and an M.B.A. from San Diego State University. His deep academic background in molecular and cellular biology, combined with business administration, provides him with a unique perspective that bridges scientific research and business strategy. This multidisciplinary expertise is instrumental in his roles across various biotech firms.

Neil Berkley's Background

Neil Berkley boasts a robust background in both scientific and business domains within the biotech industry. He previously served as the Chief Corporate Development Officer at Juvena Therapeutics and the Chief Business Officer at AbCellera. His career also includes significant roles at Halozyme Therapeutics, Axerovision, COI (Avalon Incubator), Acadia, and GSK. This diverse experience has equipped him with a comprehensive understanding of business development and corporate strategy in the biotech sector.

Neil Berkley's Achievements

Throughout his career, Neil Berkley has achieved notable successes, including co-founding and building two San Diego-based biotech companies, Mpex Pharmaceuticals and Vaxiion. His leadership and strategic vision have been pivotal in the growth and development of these companies. Additionally, his work in various high-level roles at prominent biotech firms has contributed to significant advancements and partnerships in the industry.